124 related articles for article (PubMed ID: 16882195)
21. Severe acneiform skin reaction during therapy with erlotinib (Tarceva), an epidermal growth factor receptor (EGFR) inhibitor.
Eames T; Landthaler M; Karrer S
Eur J Dermatol; 2007; 17(6):552-3. PubMed ID: 17951151
[No Abstract] [Full Text] [Related]
22. [Folliculitis caused by Pityrosporum Ovale as a diagnostic problem].
Malanin K; Kariniemi AL
Duodecim; 1996; 112(14):1293-5. PubMed ID: 10596100
[No Abstract] [Full Text] [Related]
23. Erlotinib-induced Rosacea-like Dermatitis.
Rezaković S; Paštar Z; Bukvić Mokos Z; Pavliša G; Kovačević S
Acta Dermatovenerol Croat; 2016 Apr; 24(1):65-9. PubMed ID: 27149133
[TBL] [Abstract][Full Text] [Related]
24. A Case of Perforating Folliculitis Induced by Vemurafenib.
Shiraishi K; Masunaga T; Tohyama M; Sayama K
Acta Derm Venereol; 2019 Feb; 99(2):230-231. PubMed ID: 30281138
[No Abstract] [Full Text] [Related]
25. Erlotinib-induced folliculitis decalvans.
Keith DJ; Stewart DG
Clin Exp Dermatol; 2013 Dec; 38(8):924-5. PubMed ID: 24252085
[No Abstract] [Full Text] [Related]
26. Follicular rash during therapy with erlotinib (Tarceva).
Gerdes S; Mrowietz U
J Dtsch Dermatol Ges; 2006 Oct; 4(10):855-7. PubMed ID: 17010175
[TBL] [Abstract][Full Text] [Related]
27. Pityrosporum folliculitis.
Jillson OF
Cutis; 1985 Mar; 35(3):226-7. PubMed ID: 3979106
[No Abstract] [Full Text] [Related]
28. An outbreak of Candida albicans folliculitis masquerading as Malassezia folliculitis in a prison population.
Jalalat S; Hunter L; Yamazaki M; Head E; Kelly B
J Correct Health Care; 2014 Apr; 20(2):154-62. PubMed ID: 24659762
[TBL] [Abstract][Full Text] [Related]
29. Exuberant clinical presentation of probable Malassezia folliculitis in a young nonimmunosuppressed patient.
Marques SA; Silva SB; Camargo RM; Stolf HO; Marques ME
An Bras Dermatol; 2012; 87(3):459-62. PubMed ID: 22714763
[TBL] [Abstract][Full Text] [Related]
30. Cetuximab-associated folliculitis predominantly affecting the lower limbs.
Oberholzer PA; Borradori L; Beltraminelli H
J Dtsch Dermatol Ges; 2011 Sep; 9(9):703-4. PubMed ID: 21627774
[No Abstract] [Full Text] [Related]
31. [Pityrosporum folliculitis (author's transl)].
Heid E; Grosshans E; Provencher D; Basset M
Ann Dermatol Venereol; 1978 Feb; 105(2):133-8. PubMed ID: 677682
[TBL] [Abstract][Full Text] [Related]
32. Development of Papulopustular Rosacea during Nivolumab Therapy for Metastatic Cancer.
Bousquet E; Zarbo A; Tournier E; Chevreau C; Mazieres J; Lacouture ME; Sibaud V
Acta Derm Venereol; 2017 Apr; 97(4):539-540. PubMed ID: 27826614
[No Abstract] [Full Text] [Related]
33. Folliculitis decalvans associated with erlotinib.
Hoekzema R; Drillenburg P
Clin Exp Dermatol; 2010 Dec; 35(8):916-8. PubMed ID: 20456379
[No Abstract] [Full Text] [Related]
34. Livedo reticularis with retiform purpura associated with gefitinib (Iressa).
Blume JE; Miller CC
Int J Dermatol; 2007 Dec; 46(12):1307-8. PubMed ID: 18173531
[No Abstract] [Full Text] [Related]
35. Pityrosporum folliculitis during pregnancy: a possible cause of pruritic folliculitis of pregnancy.
Parlak AH; Boran C; Topçuoglu MA
J Am Acad Dermatol; 2005 Mar; 52(3 Pt 1):528-9. PubMed ID: 15761438
[No Abstract] [Full Text] [Related]
36. Exfoliative eruption secondary to gefitinib (ZD1839).
Becuwe C; Dalle S; Arpin D; Balme B; Thomas L
Dermatology; 2007; 215(3):266-8. PubMed ID: 17823530
[No Abstract] [Full Text] [Related]
37. Purpuric drug eruption possibly due to gefinitib (Iressa).
Kurokawa I; Endo K; Hirabayashi M
Int J Dermatol; 2005 Feb; 44(2):167-8. PubMed ID: 15689221
[No Abstract] [Full Text] [Related]
38. Severe cutaneous toxicity following treatment with gefitinib (ZD1839).
Pascual JC; Belinchón I; Sivera F; Yuste A
Br J Dermatol; 2005 Dec; 153(6):1222-3. PubMed ID: 16307664
[No Abstract] [Full Text] [Related]
39. Pityrosporum folliculitis and severe pruritus in two patients with Hodgkin's disease.
Helm KF; Lookingbill DP
Arch Dermatol; 1993 Mar; 129(3):380-1. PubMed ID: 8447684
[No Abstract] [Full Text] [Related]
40. Ponatinib-induced pityriasiform, folliculocentric and ichthyosiform cutaneous toxicities.
Alloo A; Sheu J; Butrynski JE; DeAngelo DJ; George S; Murphy GF; LeBoeuf NR
Br J Dermatol; 2015 Aug; 173(2):574-7. PubMed ID: 25736577
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
